top of page
About us
A Noval Penetration Enhancer
CoR-Tech has, for the first time in nearly 200 years since the discovery of mitochondria, demonstrated the ability to directly penetrate double membranes and access mitochondria, enhancing ATP and FAD production. This innovation marks a significant milestone in direct intracellular and organelle communication.
US Patent No: 11273135 and more
HOW IT WORKS
CoR-Tech employs a novel polar solvent with unique negative charge properties. This non-toxic, nature-made impeccable molecule has been identified as the only one specifically designed for direct cellular entry into the body. Serving as both a carrier and therapeutic agent, CoR-Tech simplifies existing drug delivery systems and propels the next generation of the drug industry beyond nanotechnology and stem cell therapies.
OUR MISSION & VISION
Paving the way for a world where sickness is optional
We execute the segmental transfer of Biological Intelligence (CoR IP rights) through interested buyers, partnerships, or licensing.
bottom of page